Clinical Trials Logo

Filter by:
NCT ID: NCT06438692 Recruiting - Heart Failure Clinical Trials

Ablation Strategies for Persistent Atrial Fibrillation Combined With Heart Failure

Start date: June 16, 2022
Phase: N/A
Study type: Interventional

(1) To evaluate the efficacy and safety of "2C3L" strategy combined with VOM anhydrous ethanol chemical ablation for persistent atrial fibrillation complicated with heart failure; (2) To evaluate the effectiveness of high-efficiency ablation of atrial fibrillation complicated with heart failure.

NCT ID: NCT06438497 Recruiting - Urolithiasis Clinical Trials

The Effect of Different Body Positions and Channel Sheaths on RIRS

Start date: May 23, 2024
Phase: N/A
Study type: Interventional

Retrograde flexible ureteroscopy (RIRS) is currently the first-line treatment for renal stones < 2cm. Lower pole renal stones(LPS) are a difficult problem for urologists. The flexible negative pressure suction ureteral sheath(f-UAS) can facilitate RIRS to flush out the fragments and dust in time, and provide a clear vision and reduce the renal pelvis pressure(RPP) during operation.Standard lithotomy position is the most commonly used position for RIRS. Besides, T-tilt position is also available for RIRS in special cases. Investigators were inspired by this and proposed the lateral position, which is available in cases of LPS.In long-term practice, investigators have found that the change of position and the use of f-UAS can improve stone-free rate(SFR). Investigators aimed to conduct a prospective randomized controlled trial to compare the SFR of different positions and different ureteral sheaths.

NCT ID: NCT06438250 Recruiting - Malignant Neoplasm Clinical Trials

68Ga-FAPI-JH04 PET/CT: Dosimetry and Biodistribution Studies

Start date: March 1, 2024
Phase: Early Phase 1
Study type: Interventional

68Ga-FAPI-JH04 is a novel radiotracer targeting fibroblast activation protein (FAP). In this study, we observed the safety, biodistribution, and radiation dosimetry of 68Ga-JH040182 in patients with different types of cancer.

NCT ID: NCT06438237 Recruiting - Colonoscopy Clinical Trials

Validation of a Prediction Model for Inadequate Bowel Preparation

Start date: May 6, 2024
Phase:
Study type: Observational

We have developed a novel inadequate bowel preparation prediction model based on a systematic review and meta-analysis. The goal of this observational study is to validate the accuracy of this model.

NCT ID: NCT06437652 Recruiting - Sjogren's Syndrome Clinical Trials

An AI Algorithm for Lymphocyte Focus Score of Minor Salivary Gland Biopsy Samples for Diagnosing Sjogren's Syndrome

Start date: October 1, 2023
Phase:
Study type: Observational

The aim of this research is to discover an artificial intelligence (AI) algorithm for lymphocyte focus score in whole slide images of labial minor salivary gland (SG) biopsy samples for diagnosing Sjogren's Syndrome, in order to enhance the precision of pathological interpretation of labial minor SG biopsy samples in patients with suspected Sjogren's syndrome and aid clinicians make an accurate diagnose. A remote AI-assisted pathological interpretation platform for lymphocyte focus score in labial SG will be built for the global based on the research results. The research will propose the AI-assisted pathological interpretation of lymphocyte focus score in labial minor SG biopsy samples in the future guidelines for the diagnosis and treatment of Sjogren's syndrome. The research will: 1. Develop and debug the AI algorithm for lymphocyte focus score in whole slide images of labial minor SG biopsy samples for diagnosing Sjogren's Syndrome; 2. Internal test of the AI algorithm; 3. Clinical validation of the AI algorithm with blind method in multiple centers; 4)Built a remote AI-assisted pathological interpretation platform for lymphocyte focus score in labial SG for the global and Explore its clinical application.

NCT ID: NCT06437496 Recruiting - Clinical trials for Malignant Neoplasm of Prostate

68Ga-AAZTA-093 PET/CT: First-in-human Study

Start date: April 1, 2024
Phase: Early Phase 1
Study type: Interventional

68Ga-AAZTA-093 is a novel radiotracer targeting prostate-specific membrane antigen (PSMA). In this study, we observed the safety, biodistribution, radiation dosimetry and diagnostic value of 68Ga-AAZTA-093 PET/CT in patients with prostate cancer.

NCT ID: NCT06437353 Recruiting - Ovarian Cancer Clinical Trials

Surufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian Cancer

Start date: May 25, 2024
Phase: Phase 2
Study type: Interventional

The goal of this type of clinical trial study is to evaluate the safety and efficacy of Surufatinib combined with Carboplatin/Paclitaxel and Surufatinib combined with Olaparib as first-line and maintenance therapy for newly diagnosed high-risk ovarian cancer

NCT ID: NCT06437158 Recruiting - Clinical trials for Lymphatic Malformation

Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients

Start date: March 8, 2023
Phase: Phase 2
Study type: Interventional

Bleomycin has nowadays been more and more widely used in the sclerotherapy of LMs, which has been proven to be primarily dose dependent. The investigators aim to compare the efficacy and safety of different concentrations of Bleomycin in the sclerotherapy of LMs for pediatric patients.

NCT ID: NCT06437067 Recruiting - Clinical trials for Acute-On-Chronic Liver Failure

Study on Prognosis of Acute-on-chronic Liver Failure Complicated by Bacterial or Fungal Infection

Start date: March 1, 2023
Phase:
Study type: Observational

The subjects of this study were inpatients with ACLF who were admitted to Tongji Hospital in Wuhan from March 2023 to June 2025. After patients were enrolled, The patient's general information (gender, age, past medical history, etc.), complications (ascites, hepatic encephalopathy, hepatorenal syndrome, gastrointestinal bleeding, etc.), laboratory tests (CRP, PCT, INR, WBC, fungal/bacterial diagnostic tests, etc.), symptoms and signs at the time of infection, and at admission (D1), D4, D7, D14, D21, etc.) were recorded Save the blood separately. The patients were divided into fungal infection group, bacterial infection group and non-infection group according to the infection status after admission.

NCT ID: NCT06436950 Recruiting - Phrenic Nerves Clinical Trials

Electrical Phrenic Nerve Stimulation in Patients With VIDD

Start date: June 4, 2024
Phase: N/A
Study type: Interventional

This study aims to examine efficacy of transcutaneous electrical phrenic nerve stimulation (TEPNS) in ventilator-induced diaphragmatic dysfunction (VIDD). The investigators recruit VIDD patients, and randomly assign the patients into TEPNS group and control group. TEPNS group receives TEPNS twice a day for consecutive 5 days. Control group only receives usual care. The investigators collect diaphragm function indicators and outcomes to evaluate the efficacy.